Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Immunotherapy × Clear all

NCT06207292 2024-01-16

STARTNEWERA-OM

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT05418660 2023-09-18

I-STOP

Carcinoma, Non-Small-Cell Lung

NCT05111197 2023-02-21

TRAILOCLORI01

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

NCT05460195 2022-07-15

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT04690686 2022-03-08

Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05137912 2022-02-07

Neoadjuvant Immunotherapy in Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms